OGN News and Press, Organon & Co. From 11/19/25

2025-11-19 07:01:00 ET ... Read the full article on Seeking Alpha For further details see: IHF: Healthcare Dashboard For November

2025-11-17 12:05:00 ET ... Read the full article on Seeking Alpha For further details see: Value Investing And Benjamin Graham

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY ® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar ...

2025-11-15 11:03:40 ET More on Markets Merck & Co., Inc. (MRK) Presents at 7th Annual Healthcare Symposium Transcript Merck's Cidara Buyout Is An Opportunistic Win For Both Parties - Here's Why Boeing's Turnaround Takes Flight, But Not Yet High Enough To Buy ...

2025-11-12 05:55:00 ET According to Standard & Poor's , through October, there have been 145 dividend decreases announced by publicly traded U.S. firms during 2025.... Read the full article on Seeking Alpha For further details see: A Sampling Of Dividend Decrease...

2025-11-11 12:58:50 ET Investment Overview In my last note on Organon & Co. ( OGN ) shared in August, following the company's Q2 results, I wrote: Organon stock is down 44% year-to-date (at the time or writing), down >70% since its stock market debut, and af...

2025-11-10 10:52:27 ET More on Organon Organon & Co. (OGN) Q3 2025 Earnings Call Transcript Organon & Co. 2025 Q3 - Results - Earnings Call Presentation Organon: Critical Assessment Of The Audit Committee Investigation Results Organon cuts outlook des...

2025-11-10 10:51:36 ET Organon & Co. (OGN) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Jennifer Halchak - Head of Investor Relations Carrie Cox Joseph Morrissey - Interim CEO & Executive VP and Head of Manufacturing & Supply...

2025-11-10 08:55:55 ET More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon: Muted H2 2025 Ahead, But Distressed Valuation And Manageable Debt Makes I...

2025-11-10 08:12:19 ET Seeking Alpha (Seeking Alpha) More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon: Muted H2 2025 Ahead...